Search

Heart failure is a continuously developing syndrome of cardiac insufficiency caused by diseases, which becomes a major disease endangering human health as well as one of the main causes of death in patients with cardiovascular diseases. The occurrence of heart failure is related to hemodynamic abnormalities, neuroendocrine hormones, myocardial damage, myocardial remodeling etc, lead to the clinical manifestations including dyspnea, fatigue and fluid retention with complex pathophysiological mechanisms. Currently available drugs such as cardiac glycoside, diuretic, angiotensin-converting enzyme inhibitor, vasodilator and β receptor blocker etc are widely used for the treatment of heart failure. In particular, natural products and related active ingredients have the characteristics of mild efficacy, low toxicity, multi-target comprehensive efficacy, and have obvious advantages in restoring cardiac function, reducing energy disorder and improving quality of life. In this review, we mainly focus on the recent advance including mechanisms and active ingredients of natural products for the treatment of heart failure, which will provide the inspiration for the development of more potent clinical drugs against heart failure.

Two allyldimethylalkyl quaternary ammonium salt (AQAS) monomers, N,N-dimethylallylphenylpropylammonium bromide (AQAS1) and N,N-dimethylallylnonylammonium bromide (AQAS2), were synthesized and used to prepare modified polyacrylamide materials. Two new drag reducers were synthesized from acrylamide (AM), sodium acrylate (NaAA) and a cationic modified monomer (AQAS1 or AQAS2) via aqueous solution polymerization, and the copolymers were named P(AM/NaAA/AQAS1) and P(AM/NaAA/AQAS2), respectively. The structures of the drag reduction agents were confirmed by IR and 1H NMR spectroscopies. The molecular weight (Mw) of P(AM/NaAA/AQAS1) was 1.79 × 106 g/mol. When the copolymer concentration was 1000 mg/L and the flow rate was 45 L/min, in fresh water the highest drag reduction rate was 75.8%, in 10,000 mg/L NaCl solution the drag reduction rate decreased to 72.9%. The molecular weight of P(AM/NaAA/AQAS2) was 3.17 × 106 g/mol. When the copolymer concentration was 500 mg/L and the flow rate was 45 L/min, the drag reduction rate reached 75.2%, and in 10,000 mg/L NaCl solution the drag reduction rate was 73.3%, decreased by approximately 1.9%. The drag reduction rate for partially hydrolyzed polyacrylamide (HPAM) was also investigated, and the results showed that the drag reduction rates for 500 and 1000 mg/L HPAM solutions were merely 43.2% and 49.0% in brine, respectively. Compared with HPAM, both of the above copolymers presented better drag reduction capacities. © 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. [ABSTRACT FROM AUTHOR]